The July 1 quarterly HCPCS Level II update includes several drug/biological code changes, according to an AAPC release. Effective July 1, the HCPCS Level II code J7184 will be replaced with Q2041 Injection, Von Willebrand factor complex (human), Wilate ...

The 2028 negotiation cycle marks another major inflection point in the implementation of the Medicare Drug Price Negotiation Program—its first year incorporating Part B drugs and its first opportunity to revisit prices previously negotiated.

The bill, introduced by Sens. Rick Scott and Kirsten Gillibrand, follows a bipartisan investigation that cited ProPublica’s reporting on dangerous foreign drugmakers and the medicine they continued to sell in the U.

Senate Democrats are advancing a new prescription drug pricing agenda they say would lower costs for patients, reduce wasteful health care spending, and strengthen US biomedical innovation, while sharply criticizing Republicans—and President Donald J. Trump in particular—for what they describe as failures to deliver meaningful drug price relief. 1